Article Details
Retrieved on: 2021-10-11 10:41:15
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
... a biopharmaceutical company advancing a robust pipeline of oncology and neuroscience product candidates that are designed to uniquely disrupt cellular ...
Article found on: www.wdrb.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here